Bioworld Financial Watch articles from June 2007

Bioworld Financial Watch archives from June 2007

Genzyme buyout: 'low ball' price offered for Bioenvision.(Validates Clofarabine, But)
June 4, 2007... Genzyme Corp.'s deal to buy clofarabine partner Bioenvision Inc. for about $345 million in cash seems likely to take place in July as the firms intend, but not without grumblings from shareholders of the latter. Head scratching began with...

Collaborations between biotechnology companies and government/nonprofit institutions: March 15-May 31, 2007.
June 4, 2007... Company* University/ Type Of (Country; Symbol) Nonprofit (@) Agreement 454 Life Malaysian Genomics Resource Collaboration Sciences Corp.* Centre Advalytix AG*...

BioWorld stock report for public biotechnology companies.(Statistical table)
June 4, 2007... Close Close %Change Vol Company Symbol 5/25 6/1 WK YTD (000) Aastrom Biosci ASTM 1.42 1.41 -0.70% 14.63% 2176 Acadia Pharma ACAD ...

ASCO done, 'all eyes turn' to Amgen's fraught future.(Analyst: 'Damaged' Firm Might Be Taken)(American Society of Clinical Oncology)
June 11, 2007... Onyx Pharmaceuticals Inc. and partner Bayer Healthcare Pharmaceuticals Inc. stole the show at this year's American Society of Clinical Oncology meeting with results from the Phase III trial with Nexavar (sorafenib) in liver cancer, but plenty...

Other financings of public biotechnology companies: May 2007.(List)
June 11, 2007... TOTAL: $4,684.02M Number Of Shares, Units Amount Company Type Of Or Warrants Raised (Symbol) (#) Financing (M) ...

Venture capital and other investments in private biotechnology companies: May 2007.(List)
June 11, 2007... FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES: $517.13M Company Location Date 23andMe Inc. Mountain View, Calif. 5/23 Advanced La Jolla, Calif. 5/31 BioHealing Inc. Arete ...

Milestone payments and investments from corporate partners: May 2007.
June 11, 2007... TOTAL: $31.85M Year to Date: $169.08M Company (Symbol) (#*) Partner (Country) Amt. (M) Triggering Event Basilea Johnson & Johnson CHF24 Milestone payment Pharmaceutica Pharmaceutical ($19.6)...

Money raised by biotech in 2007: January-May.(stock market review for 2007 of biotechnology industry)(Brief article)
June 11, 2007... These graphs compare the performance of the biotech stocks for all of 2007 using two different measures. [GRAPHIC OMITTED] The BioWorld Stock Indicator measures the average percent change year to date in the 307 U.S. biotech and...

BioWorld stock report for public biotechnology companies.(List)
June 11, 2007... Close Close %Change Vol Company Symbol 6/1 6/8 WK YTD (000) Aastrom Biosci ASTM 1.41 1.37 -2.84% 11.38% 4735 Acadia Pharma ACAD 12.7...

Weighing various lupus bids: Rituxan a winner here, too?(Genentech Inc.)
June 18, 2007... Finding a drug that can re-educate the body's confusion in lupus has proven a puzzler for biotech firms for years, and opinion is divided on which companies might be getting close to a fix for the devilish disease. Is there a way to teach the...

Clinical trials update: May 2007.(Table)
June 18, 2007... Company* (Country; Symbol) Product Description AUTOIMMUNE Abbott Laboratories ABT-874 Designed to selectively inhibit (NYSE:ABT) proteins such as pro-inflammatory ...

Non-U.S. clinical trials and regulatory actions: May 2007.(Table)
June 18, 2007... Company* (Country; Symbol) Product Description CANCER Amgen Inc. (AMGN) Vectibix (FDA- Panitumumab; fully human approved) monoclonal antibody directed ...

FDA submissions, approvals and other actions: May 2007.(Table)
June 18, 2007... Company* (Country; Symbol) Product Description AUTOIMMUNE Abbott Humira Adalimumab; fully human antibody Laboratories (FDA-approved) designed to block TNF-alpha (NYSE:ABT) CANCER Cell...

BioWorld stock report for public biotechnology companies.(Statistical table)
June 18, 2007... Company Symbol Close Close % Change Vol 6/8 6/15 WK YTD (000) Aastrom Biosci ASTM 1.37 1.39 1.46% 13.01% 2264 Acadia Pharma ACAD 13.96...